104 results
Page 3 of 6
424B5
y7jo33 bu0h9
27 Apr 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.2
6b2qi wrr3
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
08jf0yz1cemeq88 2xee
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
7jyns
11 Apr 22
Zentalis Pharmaceuticals Announces Overview of Clinical and Preclinical Data Presented at AACR
4:43pm
8-K/A
q13vknxfft1
11 Apr 22
Regulation FD Disclosure
4:37pm
8-K
EX-99.2
hq8qt3yv
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
plxpgvz8pzzyrcyjig
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.1
5ojck1dssc mg4l6
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.1
7j85f8 yp
24 Feb 22
Zentalis Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
7:05am
8-K
EX-99.1
2m218544g5 d1a5
10 Nov 21
Zentalis Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update
7:48am
8-K
EX-99.1
3deix4
12 Aug 21
Zentalis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update
7:46am
8-K
EX-1.1
ok3 3irle
1 Jul 21
Other Events
4:07pm
424B5
nx1 ysfoht0kumcqi0
30 Jun 21
Prospectus supplement for primary offering
4:51pm
424B5
94sb yaskrny
28 Jun 21
Prospectus supplement for primary offering
5:30pm
8-K
kd7yxz5g8nhf 5n0fo
28 Jun 21
Other Events
7:11am